000			01607 a2200445 4500
005			20250513080246.0
264		0	_c19930315
008			199303s 0 0 eng d
022			_a0192-0561
024	7		_a10.1016/0192-0561(93)90026-u _2doi
040			_aNLM _beng _cNLM
100	1		_aAyroldi, E
245	0	0	_aPMA inhibits NK cell generation, cytotoxic activity and NK-1.1 expression. _h[electronic resource]
260			_bInternational journal of immunopharmacology _cJan 1993
300			_a11-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntigens _xdrug effects
650	0	4	_aAntigens, Ly
650	0	4	_aAntigens, Surface
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCytotoxicity, Immunologic _xdrug effects
650	0	4	_aHematopoietic Stem Cells _xdrug effects
650	0	4	_aInterleukin-2 _xpharmacology
650	0	4	_aKiller Cells, Natural _xdrug effects
650	0	4	_aLectins, C-Type
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNK Cell Lectin-Like Receptor Subfamily B
650	0	4	_aProteins _xdrug effects
650	0	4	_aTetradecanoylphorbol Acetate _xpharmacology
650	0	4	_aTumor Cells, Cultured
700	1		_aCannarile, L
700	1		_aMigliorati, G
700	1		_aRiccardi, C
773	0		_tInternational journal of immunopharmacology _gvol. 15 _gno. 1 _gp. 11-7
856	4	0	_uhttps://doi.org/10.1016/0192-0561(93)90026-u _zAvailable from publisher's website
999			_c8431892 _d8431892